Table 1.
Clinical characteristics in PCOS cases and controls
| Clinical characteristics | Control (N = 198) | PCOS (N = 212) | t | P | P adj |
|---|---|---|---|---|---|
| BMI (kg/m2) | 22.32±3.64 | 27.51±3.75 | 0.042 | 0.047 | 0.231 |
| Age (year) | 36.1±5.33 | 28.2±4.72 | 0.257 | 0.039 | 0.342 |
| HC (cm) | 96.34±8.18 | 95.60±7.73 | 0.513 | 0.574 | 0.281 |
| WC (cm) | 86.90±12.44 | 86.30±10.16 | 0.350 | 0.701 | 0.640 |
| WHR | 0.88±0.12 | 0.86±0.06 | 0.152 | 0.684 | 0.534 |
| FSH (IU/L) | 6.48±1.72 | 21.29±1.76 | 1.100 | 0.324 | 0.186 |
| LH (IU/L) | 11.72±6.51 | 10.32±3.10 | 1.238 | 0.260 | 0.143 |
| T (ng/dl) | 46.78±11.64 | 39.06±14.53 | 3.221 | 0.351 | 0.244 |
| LH/FSH | 1.84±0.74 | 1.62±0.81 | 1.606 | 0.143 | 0.156 |
| FPG (mmol/L) | 5.62±1.37 | 5.64±1.21 | 0.114 | 0.871 | 0.803 |
| 2hPG (mmol/L) | 6.97±2.47 | 6.66±2.51 | 0.719 | 0.384 | 0.334 |
| FINS (mIU/L) | 12.67±5.83 | 13.37±4.31 | 0.256 | 0.787 | 0.716 |
| 2hINS (mIU/L) | 78.13±26.04 | 70.10±36.08 | 0.648 | 0.450 | 0.380 |
| HOMA-IR | 3.407±2.873 | 3.419±2.604 | 0.031 | 0.921 | 0.766 |
| CHOL (mmol/L) | 4.85±0.88 | 4.61±0.92 | 1.319 | 0.204 | 0.147 |
| TG (mmol/L) | 1.41±0.93 | 1.36±1.15 | 0.347 | 0.763 | 0.679 |
| HDL-C (mmol/L) | 1.36±0.38 | 1.34±0.31 | 0.196 | 0.824 | 0.735 |
| LDL-C (mmol/L) | 3.38±0.89 | 3.40±0.95 | 0.248 | 0.608 | 0.595 |
Independent student’s t test and Mann-Whitney U-test; Data are expressed as mean ± SD; PCOS: Polycystic ovary syndrome; BMI: body mass index; FSH: follicle-stimulating hormone; LH: luteinizing hormone; T: testosterone; CHOL: total cholesterol; TG: triglycerides; HDL-C: High-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol. P adj: P value after age and BMI adjustment in logistic regression.